U.S. markets closed

Boston Properties, Inc. (BXP)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
76.50+2.84 (+3.86%)
At close: 04:00PM EDT
76.74 +0.24 (+0.31%)
After hours: 05:18PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close73.66
Bid73.23 x 1000
Ask78.29 x 900
Day's Range73.47 - 77.30
52 Week Range73.41 - 133.11
Avg. Volume1,285,795
Market Cap11.99B
Beta (5Y Monthly)1.15
PE Ratio (TTM)18.21
EPS (TTM)4.20
Earnings DateOct 24, 2022 - Oct 28, 2022
Forward Dividend & Yield3.92 (5.08%)
Ex-Dividend DateSep 29, 2022
1y Target Est98.95
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-17% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BXP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Boston Properties, Inc.
    Analyst Report: Boston Properties, Inc.Boston Properties Inc. is a real estate investment trust (REIT). The company is one of the largest owners and developers of Class A office properties in the U.S. The company's assets include offices, hotels, retail, and residences; however, about 90% of revenues are from office space. The portfolio is concentrated in large coastal cities, including Boston, Los Angeles, New York, San Francisco, and Washington, D.C. At the end of 2021, the company expanded into the Seattle market. BXP's portfolio consists of 201 properties with 53 million square feet. BXP's top 20 tenants represent about 29% of annualized rent, and have a remaining weighted-average lease term of 10.6 years. Tenant diversification is as follows: financial services/investment banking, 23%; legal, 21%; tech/media, 20%; financial services, 16%; insurance, 8%; life sciences, 7%; and retail, 6%. The shares are included in the S&P 500.
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • Zacks

    Boston Properties' (BXP) Buyout Boosts Life-Science Portfolio

    Boston Properties (BXP) acquires 125 Broadway in Kendall Square in Cambridge, MA, from Biogen for $592 million. The move aids its expansion efforts in the life sciences space in Cambridge.

  • American City Business Journals

    Biogen sells one Kendall Square building, ends lease on another

    Biogen Inc. has sold a six-floor lab building in Kendall Square to Boston Properties Inc. for $603 million and ended its lease early on a nearby office building, as part of its continued drive to shrink its real estate footprint.

  • Business Wire

    BXP Expands Life Sciences Portfolio in Kendall Square in Cambridge, MA

    BOSTON, September 20, 2022--BXP (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that it completed the acquisition of 125 Broadway, a six-story, 271,000 square foot laboratory/life sciences property. BXP purchased the property from Biogen for a gross purchase price of approximately $592.0 million. Biogen has signed a lease for and will continue to occupy the entire property through April 2028. BXP funded the purcha